Comparing lipid levels in diabetic and non-diabetic patients with chronic kidney disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to compare blood lipid levels in participants over 20 years old with chronic kidney disease (CKD), both with and without diabetes. The primary objective is to determine whether diabetes exacerbates lipid abnormalities in CKD patients. Participants will undergo a 10-hour fasting period before blood samples are collected and analyzed in a laboratory. The findings could provide insights into the relationship between diabetes and lipid metabolism in CKD.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients of chronic kidney disease (CKD) presenting to the Sohag University Hospital
* Patients aged above 20 years of age.
* All patients who have given consent for enrolling into the study.

Exclusion Criteria:

* Patients aged 20 years of age or below.
* Patients on lipid-lowering drugs.
* Kidney transplanted patients.

Where it's running

• Department of Internal Medicine , Sohag University Hospital.
  Sohag, Egypt Recruiting

Study contacts

• Study coordinator: Shaimaa Mahmoud Elsayed Abdel-Raheem
• Email: shimaa4848@gmail.com
• Phone: +201119193276

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How the blood-vessel lining and oxidative stress affect microcirculation in chronic kidney disease

  This project will test whether changes in the blood-vessel lining (glycocalyx) and oxidative stress are linked to poorer small-vessel blood flow in people with chronic kidney disease compared with people who have high blood pressure and healthy volunteers.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07437729

• Observational look at how Kremezin works in adults with advanced chronic kidney disease

  This study tests whether Kremezin helps adults with advanced kidney disease when used as part of routine care, by tracking safety and kidney function over up to 48 weeks.

  Recruiting HK inno.N Corporation · Seoul · NCT07930169

• Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China

  This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.

  Recruiting Phase 4 Novo Nordisk A/S · Fuyang, Anhui and 25 other locations · NCT07900438

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.